Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '619478'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '619477'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '158900'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '158901'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '600416'
      Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Modifying germline mutation in
      ExternalReferences: []
      Name: DNA methyltransferase 3 beta
      Symbol: DNMT3B
  - Gene:
      DisorderGeneAssociationType: Disease-causing germline mutation(s) in
      ExternalReferences: []
      Name: structural maintenance of chromosomes flexible hinge domain containing
        1
      Symbol: SMCHD1
  - Gene:
      DisorderGeneAssociationType: Modifying germline mutation in
      ExternalReferences: []
      Name: structural maintenance of chromosomes flexible hinge domain containing
        1
      Symbol: SMCHD1
  Label: Facioscapulohumeral dystrophy
  ORPHAcode: '269'
  ORPHApacketId: '269'
  PURL: http://www.orpha.net/ORDO/Orphanet_269
  Parents:
  - Parent:
    - Label: Progressive muscular dystrophy
      ORPHAcode: '206644'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000298
      HPOTerm: Mask-like facies
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003202
      HPOTerm: Skeletal muscle atrophy
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003236
      HPOTerm: Elevated circulating creatine kinase concentration
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003307
      HPOTerm: Hyperlordosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003457
      HPOTerm: EMG abnormality
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000407
      HPOTerm: Sensorineural hearing impairment
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000499
      HPOTerm: Abnormal eyelash morphology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0008046
      HPOTerm: Abnormal retinal vascular morphology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100540
      HPOTerm: Palpebral edema
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030680
      HPOTerm: Abnormality of cardiovascular system morphology
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19320656[PMID]_22217918[PMID]_19767415[PMID]_[EXPERT]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19320656[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19767415[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 1745328[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 25122204[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 25122204[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: FSH dystrophy
  - Synonym: FSHD
  - Synonym: Facioscapulohumeral muscular dystrophy
  - Synonym: Facioscapulohumeral myopathy
  - Synonym: Landouzy-Dejerine dystrophy
  - Synonym: Landouzy-Dejerine myopathy
  TextSection:
    Contents: A rare neuromuscular disease characterized by progressive muscle weakness
      with focal involvement of the facial shoulder and limb muscles.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Autosomal dominant
  copyright: Orphanet (c) 2023
  creationDate: '2023-06-22 11:33:23'
  version: 1.3.25 / 4.1.7 [2023-04-17] (orientdb version)
